Ozop Energy Solutions Announces New Subsidiary

WARWICK, N.Y., Jan. 07, 2021 (GLOBE NEWSWIRE) —

Ozop Energy Solutions
. (OZSC), (“Ozop” or the “Company”), is pleased to announce the formation of a new subsidiary Ozop Energy Systems, Inc.

Ozop Energy Systems vision is to be a global leader of supply chain solutions within the renewable energy market. With the coming growth surge in renewable energy, we expect to capture a substantial share of these emerging and maturing sectors.

“Throughout our 29 years, PCTI has developed a rich history of manufacturing partners, enabling us to engineer and distribute additional product lines beyond what we manufacture in house. As the deployment of energy storage projects increases globally, we found an opportunity to provide one-stop-shopping for not only our clients, but for the industry,” stated Brian P Conway, Chief Executive Officer of OZSC. “Ozop Energy Systems will address customer project demand streams through our online catalogue portal or directly with our procurement specialists interfacing directly with suppliers around the globe. Whether it’s an EV station or an entire municipal storage grid, Ozop Energy Systems will be the key resource of top-quality products and solutions via our premier manufacturing partners”

For more information on PCTI please follow on the link, www.pcti.com.

Please be aware that our social media accounts can be used from time to time for additional material events.


https://twitter.com/OzopEnergy


https://www.facebook.com/OzopEnergy/


The Waypoint Refinery (discord.com)

About Ozop Energy Solutions.

Ozop Energy Solutions (http://ozopenergy.com/) invents, designs, develops, manufactures, and distributes ultra-high power chargers, inverters, and power supplies for a wide variety of applications in the defense, heavy industrial, aircraft ground support, maritime and other sectors. Our strategy focuses on capturing a significant share of the rapidly growing renewable energy market as a provider of assets and infrastructure needed to store energy.

About Power Conversion Technologies, Inc.

Power Conversion Technologies, Inc. (www.pcti.com) invents, designs, develops, manufactures and distributes standard and custom power electronic solutions. Founded in 1991 and located in East Butler, Pennsylvania, the Company’s mission is to be the global leader for high power electronics with a standard of continued innovation.

Safe Harbor Statement

“This press release contains or may contain, among other things, certain forward-looking statements. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the company’s plans, objectives, projections, expectations and intentions and other statements identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential” or similar expressions. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties, including those detailed in the company’s filings with the Securities and Exchange Commission. Actual results may differ significantly from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the company’s control). The company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.”

###

Investor Relations Contact

The Waypoint Refinery, LLC
845-397-2956
www.thewaypointrefinery.com



Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer

CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced the appointment of Brendan Delaney to the newly created position of Chief Commercial Officer, effective January 11, 2021. In this role, Mr. Delaney will be responsible for building and leading the Company’s commercial organization and pre-launch preparations in support of CPI-0610, which has the potential to be a disease-modifying therapy for patients living with myelofibrosis.

“Brendan is joining Constellation at a pivotal time, and I look forward to working with him to advance the treatment paradigm for patients with myelofibrosis,” said Jigar Raythatha, President and Chief Executive Officer of Constellation Pharmaceuticals. “With more than 25 years of experience in hematology and oncology commercialization, Brendan’s expertise will be invaluable as we prepare for the potential launch of our first product, CPI-0610—the first potential new myelofibrosis therapy beyond JAK inhibitors.”

“I am excited to join Constellation and look forward to leading preparations for the Company’s first commercial product launch,” said Brendan Delaney, Chief Commercial Officer of Constellation Pharmaceuticals. “It’s gratifying to work toward advancing the standard of care for patients with myelofibrosis. CPI-0610 is a highly promising Phase 3 product candidate with the potential to address unmet medical needs that have been identified by both patients and physicians.”

Mr. Delaney has a track record of global commercial success that spans more than two decades in the biopharmaceutical industry. Prior to joining Constellation, Mr. Delaney served as Chief Commercial Officer at Immunomedics, where he built and led the marketing, sales, market access, and commercial operations teams in preparation for that Company’s first commercial product launch. Previously, he served in several senior positions of increasing responsibility at Celgene, including most recently as Vice President, U.S. Commercial Hematology Oncology. Earlier in his career, Brendan held various sales, marketing and product management roles at Novartis Oncology and Genentech, where he directed successful product launches for several blockbuster brands. He earned an MBA from the Stern School of Business at New York University and a B.A. in biology from Rutgers University.

About Constellation Pharmaceuticals 

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease progression and drug resistance. Constellation is advancing development of the BET inhibitor CPI-0610 for the treatment of myelofibrosis as well as the EZH2 inhibitor CPI-0209 for the treatment of solid tumors. The Company is also applying its broad research and development capabilities to explore other novel targets that directly and indirectly impact gene expression to fuel a sustainable pipeline of innovative, small-molecule product candidates.

Forward-Looking Statements  

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding the Company’s regulatory and commercial plans and prospects of the Company’s product candidate, CPI-0610.  Any forward-looking statements are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in, or implied by, such forward-looking statements. These risks and uncertainties include, but are not limited to, risks associated with the Company’s ability to: obtain and maintain necessary approvals from the FDA and other regulatory authorities; replicate in later clinical trials positive results found in preclinical studies and early-stage clinical trials; obtain, maintain, or protect intellectual property rights related to its product candidates; manage expenses; raise the substantial additional capital needed to achieve its business objectives; the COVID-19 pandemic; and general economic and market conditions. For a discussion of other risks and uncertainties, any of which could cause the Company’s actual results to differ from those contained in the forward-looking statements, see the “Risk Factors” section, as well as discussions of potential risks, uncertainties, and other important factors, in the Company’s most recent filings with the Securities and Exchange Commission.

Contacts 

Kia Khaleghpour, Ph.D. 
Vice President, Investor Relations and Communications 
Constellation Pharmaceuticals 
+1 617-844-6859 
[email protected] 
  
Lauren Arnold 
Media Relations 
MacDougall Biomedical Communications 
+1 781-235-3060 
[email protected]  

 



Access-Power & Co., Inc. is pleased to announce today that our new e-Commerce website Hempster19.com is alive and accepting orders

GRAND HAVEN, Mich., Jan. 07, 2021 (GLOBE NEWSWIRE) — Access-Power & Co., Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company, is pleased to announce Hempster19.com is ALIVE and accepting orders today.   The Company stated, “Please visit our website, and place an order today for one of our GIFT SETs on sale.”

Patrick J Jensen our Director commented, “ACCR is innovating, creating, and executing on all business plan fronts. We are so excited about driving traffic to this new website creation.” He added, “This business plan makes sense going into 2021 and beyond. We believe the Covid-19 aggression will be slowed with the Hemp Infused Hand Sanitizer market.”

https://www.hempster19.com    

Established in 1996, Access-Power & Co., Inc. is a Florida based for-profit Corporation with operations in West Michigan.

There are various risk factors that should be carefully considered in evaluating our business; because such factors may have a significant impact on our business, our operating results, our liquidity and financial condition. As a result of these various risk factors, actual results could differ materially from those projected in any forward-looking statements. Additional risks and uncertainties not presently known to us, or that we currently consider to be immaterial, may also impact our business, result of operations, liquidity and financial condition. If any such risks occur, our business, its operating results, liquidity and financial condition could be materially affected in an adverse manner. Under such circumstances, if a stable trading market for our securities is established, the trading price of our securities could decline, and you may lose all or part of your investment.

SECURITIES ISSUED BY THE COMPANY INVOLVE A HIGH DEGREE OF RISK AND, THEREFORE, SHOULD BE CONSIDERED EXTREMELY SPECULATIVE. THEY SHOULD NOT BE PURCHASED BY PERSONS WHO CANNOT AFFORD THE POSSIBILITY OF THE LOSS OF THE ENTIRE INVESTMENT. PROSPECTIVE INVESTORS SHOULD READ ALL OF THE COMPANY’S FILINGS, INCLUDING ALL EXHIBITS, AND CAREFULLY CONSIDER, AMONG OTHER FACTORS THE VARIOUS RISK FACTORS THAT MAY BE PRESENT.

BEWARE OF NAKED SHORTING IN OUR COMMON SHARES

You should be aware that there are many substantial risks to an investment in our common stock. Carefully consider these risk factors, along with any available information currently reported by the Company (of which there are note), before you decide to invest in shares of our common stock.   If these risk factors were to occur, our business, financial condition, results of operations or future prospects could be materially adversely affected. If that happens, the market price for our common stock, if any, could decline, and prospective investors would likely lose all or even part of their investment.

Cautionary Language Concerning Forward-Looking Statements

Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”, and similar expressions, as they relate to the Company or its management, identify forward-looking statements. These statements are based on current expectations, estimates, and projections about the Company’s business, based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors.
Contact Information:

Patrick J. Jensen
Director
Tel:  616.312.5390
Email:  [email protected]
Corporate Website:  http://www.myaccess-power.com
“Our corporate website is currently under construction to soon reflect our new business model in the Michigan Medical Marijuana Clone sector.”

Product Website
https://www.mycbdpets.com


https://www.clonesbydrones.com


https://www.clonesbycars.com



https://www.hempster19.com

Access-Power & Co., Inc. 
OTC Ticker:  ACCR



Bitfarms Announces Closing of CAD$20.0 Million Private Placement with U.S. Institutional Investors

Bitfarms Announces Closing of CAD$20.0 Million Private Placement with U.S. Institutional Investors

TORONTO & BROSSARD, Québec–(BUSINESS WIRE)–
Bitfarms Ltd. (“Bitfarms”, or the “Company”) (TSXV:BITF) (U.S.:OTC:BFARF), one of the largest and most productive publicly listed bitcoin mining operations in the world, is pleased to announce that it has closed its previously announced private placement of equity securities (the “Offering”). The Offering was for gross proceeds of approximately CAD$20 million and consisted of the sale of 8,888,889 common shares, along with warrants to purchase an aggregate of up to 8,888,889 common shares, at a purchase price of CAD$2.25 per common share and associated warrant. The warrants have an exercise price of CAD$2.75 per common share and exercise period of three years (through January 8, 2024). The funds were raised via a fully subscribed private placement of Units among U.S. institutional investors.

H.C. Wainwright & Co. acted as the exclusive placement agent for the Offering.

The net proceeds of the Offering will be used principally to acquire additional miners, expand infrastructure, and improve its working capital position.

H.C. Wainwright & Co. received (i) a cash commission equal to 8.0% of the gross proceeds of the Offering and (ii) 711,111 non-transferable broker warrants (the “Broker Warrants”), with each Broker Warrant exercisable for one common share of the Company at a price of CAD$2.81 at any time on or before January 8, 2024.

The securities issued under the Offering are subject to customary resale restrictions in the United States with no resale restrictions in Canada.

Notes

The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States except pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933 and applicable state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

About Bitfarms Ltd.

Bitfarms is one of the largest public bitcoin mining operations in the world and is listed on the TSX-V. Founded in 2017 it has five industrial scale facilities across Quebec, Canada and is responsible for infrastructure activities of approximately 1% of the entire Bitcoin mining industry and daily Bitcoin mined. Bitfarms run vertically integrated mining operations with onsite technical repair, data analytics and engineers to deliver the computing power needed to drive the rapid growth of the global decentralized financial economy.

Website: www.bitfarms.com

https://www.facebook.com/bitfarms/

https://twitter.com/Bitfarms_io

https://www.instagram.com/bitfarms/

https://www.linkedin.com/company/bitfarms/

Cautionary Statement

Trading in the securities of the Company should be considered highly speculative. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities laws that are based on expectations, estimates and projections as at the date of this news release. The information in this release about future plans and objectives of the Company and the expected expenditure of the proceeds of the Offering, are forward-looking information. Other forward-looking information includes but is not limited to information concerning: the intentions, plans and future actions of the Company, as well as Bitfarms’ ability to successfully mine digital currency, revenue increasing as currently anticipated, the ability to profitably liquidate current and future digital currency inventory, volatility of network difficulty and digital currency prices and the resulting significant negative impact on the Company’s operations, the construction and operation of expanded blockchain infrastructure as currently planned, and the regulatory environment of cryptocurrency in the Provinces of Canada.

Any statements that involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information and are intended to identify forward-looking information.

This forward-looking information is based on reasonable assumptions and estimates of management of the Company at the time it was made, and involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. Such factors include, among others: risks relating to the global economic climate; dilution; the Company’s limited operating history; future capital needs and uncertainty of additional financing; the competitive nature of the industry; currency exchange risks; the need for the Company to manage its planned growth and expansion; the effects of product development and need for continued technology change; protection of proprietary rights; the effect of government regulation and compliance on the Company and the industry; network security risks; the ability of the Company to maintain properly working systems; reliance on key personnel; global economic and financial market deterioration impeding access to capital or increasing the cost of capital; and volatile securities markets impacting security pricing unrelated to operating performance. In addition, particular factors which could impact future results of the business of Bitfarms include but are not limited to: the construction and operation of blockchain infrastructure may not occur as currently planned, or at all; expansion may not materialize as currently anticipated, or at all; the digital currency market; the ability to successfully mine digital currency; revenue may not increase as currently anticipated, or at all; it may not be possible to profitably liquidate the current digital currency inventory, or at all; a decline in digital currency prices may have a significant negative impact on operations; an increase in network difficulty may have a significant negative impact on operations; the volatility of digital currency prices; the anticipated growth and sustainability of hydroelectricity for the purposes of cryptocurrency mining in the Province of Québec, the ability to complete current and future financings, any regulations or laws that will prevent Bitfarms from operating its business; historical prices of digital currencies and the ability to mine digital currencies that will be consistent with historical prices; an inability to predict and counteract the effects of COVID-19 on the business of the Company, including but not limited to the effects of COVID-19 on the price of digital currencies, capital market conditions, restriction on labour and international travel and supply chains; and there will be no regulation or law that will prevent Bitfarms from operating its business. The Company has also assumed that no significant events occur outside of the Bitfarms’ normal course of business. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company undertakes no obligation to revise or update any forward-looking information other than as required by law.

For corporate inquiries, please contact:

Geoff Morphy

[email protected]

647-500-7440

For media inquiries, please contact:

Ellis Ballard

[email protected]

011-07725951640

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Networks Finance Hardware Banking Data Management Professional Services Technology Security

MEDIA:

CleanSpark, Inc. Commences Residential Estate Program with Bay Area Energy Solutions, Inc.

Companies Launch Initiative with First Luxury Deployment

PR Newswire

SALT LAKE CITY, Jan. 7, 2021 /PRNewswire/ — CleanSpark, Inc. (Nasdaq: CLSK), (“CleanSpark, or the Company”), an advanced software and controls technology solutions company focused on solving modern energy challenges, and Bay Area Energy Solutions, Inc. today announced they are jointly developing the first pilot microgrid solution for an estate residence in Healdsburg, CA.  The companies are pleased to have secured the first contract under a previously announced partnership agreement.

 

CleanSpark Launches Luxury Estate Energy Program Following Successful Bitcoin Deployment

 This initial project is anticipated to be the first of a joint initiative formed with a number of domestic energy developers, including Bay Area Energy Solutions.  Luxury and estate homes offer a targeted niche with unique requirements for which CleanSpark and its partners can provide strategic solutions. Properties of this size often require significant power for one or more building structures and can even include business operations on site. There are thousands of homes greater than 10,000 square feet in the state of California alone, where incentives and tax benefits, along with well-documented utility challenges support the implementation of new, renewable, and resilient energy sources. CleanSpark expects to develop a significant pipeline of projects within this sector.

The first deployment is a 14,000 square foot estate currently under construction. When completed, the luxury residence will be operated fully grid-disconnected, utilizing on site generation, solar, and storage managed by CleanSpark’s mPulse Controller for system optimization. The goal of the project is to provide self-sufficient off-grid energy for locations frequently experiencing grid disruptions from events including wildfires and public safety grid shutdowns. The California Energy Commission anticipates increasing volatility in areas prone to disruptions.

Kilowatt Labs, Inc.’s supercapacitor-based energy storage which will be installed with photovoltaic solar panels during the first phase of the project in order to power construction of the home. Additional solar and stand-by generators will be added once the homeowner takes residence.

Amer Tadayon CRO of CleanSpark commented, “We are seeing increasing investments being made by estate homeowners integrating sustainable energy technology into construction projects of this magnitude, and we believe this trend will continue. This is the first foray directly into this market segment for CleanSpark. With our development partners, we can help solve critical energy and resiliency challenges for these types of residences.” Adding, “We are pleased to continue building our pipeline of microgrid projects with partners like Bay Area Energy Solutions, where we expect to deploy multiple mPulse controlled residential microgrids in 2021.”

Joel Ware, owner of Bay Area Energy Solutions said, “Because this is an off-grid project, we worked with a number of energy providers including Kilowatt Labs to procure the proper electrical generation and storage for the construction phase, as well as the permanent occupancy of the home. CleanSpark’s Controller will enable our customer to power their home and property efficiently, with self-sufficient, sustainable energy that is not reliant on the increasingly volatile utility grid.”

Zach Bradford CEO of CleanSpark said of the project, “We are excited to participate on this project with Bay Area Energy. CleanSpark’s proprietary mPulse system, paired with solar, storage, and generators will provide complete resiliency as well as significant cost savings. It will also allow their microgrid to be ‘future-proof’ should they wish to add additional solar or other resources at a later date.  We believe that the sustainable energy management opportunities presented within the higher end residential real estate market will parallel the successes we’ve begun to experience in our Bitcoin mining operations.”

Parties interested in learning more about CleanSpark products and services are encouraged to inquire by contacting the Company directly at [email protected] or visiting the Company’s website at www.cleanspark.com.

Investors are encouraged to contact the Company at [email protected], or visiting the Company’s website at https://ir.cleanspark.com/

About CleanSpark:

CleanSpark, Inc., a Nevada corporation, is in the business of providing advanced software and controls technology solutions to solve modern energy challenges.  We have a suite of software solutions that provide end-to-end microgrid energy modeling, energy market communications, and energy management solutions.  Our offerings consist of intelligent energy monitoring and controls, intelligent microgrid design software, middleware communications protocols for the energy industry, energy system engineering, and software consulting services. 

Through its wholly owned subsidiary ATL Data Centers LLC, CleanSpark owns and operates a data center that provides customers with traditional on-site and cloud-based data center services. The Company also owns and operates a fleet of over 3,400 ASIC (application-specific integrated circuit) Bitcoin miners producing over 200 PH/s in mining capacity. Capacity is expected to increase to over 5,900 ASIC and 300 PH/s in mining capacity by early 2021. CleanSpark plans to apply its technologies with a goal of mining bitcoins at the lowest energy prices in the United States. For more information, visit https://ATL-DATA.com

About Bay Area Energy Solutions, Inc.:

Bay Area Energy Solutions, Inc. provides custom solar design and installation services for residential and commercial properties in the Greater California Bay Area. Bay Area Energy Solutions, Inc. is proud to be a certified Sunpower dealer, and a Tesla PowerWall authorized installer.

Forward-Looking Statements:

CleanSpark cautions you that statements in this press release that are not a description of historical facts are forward-looking statements. These statements are based on CleanSpark’s current beliefs and expectations. The inclusion of forward-looking statements should not be regarded as a representation by CleanSpark that any of our plans will be achieved. Actual results may differ from those set forth in this press release due to the risk and uncertainties inherent in our business, including, without limitation: the successful deployment energy solution on the project, the fitness of our energy software and solutions for this particular application or market, the expectations of future revenue growth may not be realized, ongoing demand for our software products and related services, the impact of global pandemics (including COVID-19) on the demand for our products and services; and other risks described in our prior press releases and in our filings with the Securities and Exchange Commission (SEC), including under the heading “Risk Factors” in our Annual Report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and we undertake no obligation to revise or update this press release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Contact – Investor Relations:
CleanSpark Inc.
Investor Relations
(801)-244-4405

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cleanspark-inc-commences-residential-estate-program-with-bay-area-energy-solutions-inc-301202645.html

SOURCE CleanSpark, Inc.

Tarsus Pharmaceuticals, Inc. Appoints Dianne Whitfield as Chief Human Resources Officer

IRVINE, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced the appointment of Dianne Whitfield to the position of Chief Human Resources (HR) Officer. Ms. Whitfield has more than 20 years of experience in human resources, including over a decade of management and leadership experiences in the life sciences industry.

Most recently, Ms. Whitfield served as Vice President and Head of Human Resources for Evolus, Inc., where she led efforts to support the commercialization of the startup company’s first approved product. While at Evolus, she designed strategy and executed programs focused on recruiting top talent and building a positive culture and an effective employee experience, to drive engagement and business results.

“Dianne’s appointment to the position of Chief HR Officer comes at an incredibly exciting time for our business, as we lay the foundation for long-term organizational growth,” said Bobak Azamian, MD, PhD, CEO, Tarsus Pharmaceuticals, Inc. “Dianne brings a wealth of leadership experience, including her recent tenure at Evolus, where she built a talented, multifunctional team in a growing startup, defined an engaging culture, and supported the launch of a new pharmaceutical product. We look forward to Dianne’s leadership as we continue to build the Tarsus team and a culture that will best enable our company’s mission.”

Prior to Evolus, Ms. Whitfield held positions of increasing responsibility at Allergan (an AbbVie company) where she progressed to the role of Director of Global Human Resources. Her experience there spanned a variety of human resources business partnership and leadership roles where she supported both the Commercial and Research & Development organizations and led enterprise-wide initiatives in Global Talent Management. She has broad experience building organizations and supporting product launches in multiple therapeutic areas including eye care, as well as expertise in developing culture and talent programs to drive organizational success. Dianne holds a Bachelor of Arts in Psychology and Social Behavior from the University of California, Irvine and a Masters in Social Work from California State University, Long Beach.

“I’m thrilled to join the experienced and talented management team at Tarsus, and look forward to driving its next phase of growth by curating a differentiated culture that captures the Tarsus spirit of innovation, and enables talent to achieve our mission,” said Ms. Whitfield.

About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.

Forward-Looking Statements

Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements.” These statements include statements regarding future events and Tarsus’ plans for and the anticipated benefits of its product candidates, the timing, objectives and results of the clinical studies and anticipated regulatory and development milestones. The words, without limitation, “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will” or “would” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, and are detailed from time to time in the reports Tarsus files with the Securities and Exchange Commission, copies of which are posted on its website and are available from Tarsus without charge. However, new risk factors and uncertainties may emerge from time to time, and it is not possible to predict all risk factors and uncertainties. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements. Any forward-looking statements contained in this press release are based on the current expectations of Tarsus’ management team and speak only as of the date hereof, and Tarsus specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Media Contact:

Allison Howell
Pascale Communications, LLC
[email protected]

Investor Contact:

Patti Bank
Westwicke Partners, an ICR company
(415) 513-1284
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5be39cb4-2eac-49dc-9d36-4eedaaca35c9



Life Care Services to Manage 6 Senior Living Communities

Rose Senior Living selects nation’s second-largest operator

Des Moines, Iowa, Jan. 07, 2021 (GLOBE NEWSWIRE) — Life Care Services, An LCS Company, has been selected to manage the Rose Senior Living portfolio of six senior living communities. The partnership was effective December 31, 2020. Rose Senior Living, owned by Edward Rose & Sons, is in Bloomfield Hills, Michigan.

“Our leadership and community teams are focused on delivering services that gain high resident satisfaction for Rose Senior Living,” says Chris Bird, EVP and chief operating officer for LCS. “Life Care Services will build on the services already in place, placing our focus on the health and well-being for all residents living in these six communities.”

With the agreement in place, Life Care Services will manage these communities: Heritage at Irene Woods, Memphis, Tennessee; Rose Senior Living and Rose Villas, Avon, Ohio; Rose Senior Living, Beachwood, Ohio; Rose Senior Living, Carmel, Indiana; Rose Senior Living, Clinton Township, Michigan; and Rose Senior Living at Providence Park, Novi, Michigan.

“We look forward to our partnership with Life Care Services,” says Warren Rose, chief executive officer. “Throughout the selection process, the team demonstrated their responsive and professional approach to senior living. It’s clear — Life Care Services brings passion to the seniors they serve.”

Included in the agreement is management of a seventh community, Rose Senior Living, Farmington Hills, Michigan, scheduled to break ground sometime in 2021.

About Life Care Services

Life Care Services, An LCS Company, has the experience required to boost community financial performance, increase occupancy, and develop new lifestyle and health initiatives to meet consumer expectations and help communities thrive. With a long track record of excellence, Life Care Services, sets itself apart from other senior living companies with its unique, comprehensive portfolio of support services. Life Care Services is the nation’s second largest operator of senior living communities and has expertise in the management of both Life Plan and rental communities. From independent living to assisted living, skilled nursing to memory care, at Life Care Services, Experience Is Everything. For more information, visit lifecareservicesLCS.com.



Pat Howard
Life Care Services
5158837938
[email protected]

JIECANG Garners Sole Industry Selection at Inaugural “Future Factory” Conference

PR Newswire

HANGZHOU, China, Jan. 7, 2021 /PRNewswire/ — JIECANG was the only company to be selected in its industry when the first batch of future factories was named at the inaugural “Future Factory” conference which was recently held in Hangzhou, Zhejiang Province in China.

A “Future Factory” mainly consists of features in five aspects: intelligent manufacturing, modern management, model innovation, city-industry integration, and sustainable development and aims to create a new model and benchmark for smart manufacturing. JIECANG “Future Factory” project is in Xinchang Provincial High-tech Industrial Park, with a total construction area of approximately 70,000 square meters where people, machines and products communicate and interact autonomously, providing customers with more effective customized services. 

JIECANG currently has numerous automated processes, including parts manufacturing, finished product assembly, quality inspection, packaging, and inventory management. Digital twin solutions are widely applied to customized products. Professional software is used in modeling, simulating performance and optimizing design, shortening the product delivery cycle by more than 30%.

JIECANG intelligent workshop uses high-precision equipment, a centralized feeding system, and an intelligent equipment management system to ensure rapid and accurate parts manufacturing. The integrated energy management system can monitor energy consumption in real time, and continuously optimize through data analysis, reducing consumption to realize the goal of green manufacturing.

Through intelligent management and collaborative manufacturing, the company closely coordinates global customer needs, R&D centers, production bases with planned execution, product delivery, and after-sales service, to quickly respond to customer needs, shorten product development cycles and customer deliveries. With continuous cultivation and development, JIECANG “Future Factory” will realize efficient collaboration through the industrial Internet platform and form an intelligent manufacturing system integrating “quality, efficiency and environmental protection”.

ABOUT JIECANG

JIECANG, a technology group focusing on the research, development, production and sales of linear motion products, integrates global resources, provides intelligent motion and control solutions for industries like smart office, medical care, smart home and industrial automation using technology to drive intelligent life. With 20 years of industry experience, JIECANG responds quickly to customers’ requirements and endeavors to become a world-leading solutions provider in linear motion systems and promote downstream product intelligent transformation, bringing the new values of intelligence, health (ergonomics) and fun to its new products. For more information, please visit us at en.jiecang.com.   

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/jiecang-garners-sole-industry-selection-at-inaugural-future-factory-conference-301202828.html

SOURCE JIECANG

First patient in treatment in RhoVac’s clinical phase IIb study in United Kingdom

PR Newswire

STOCKHOLM, Jan. 7, 2021 /PRNewswire/ — RhoVac AB (“RhoVac”) announces today, on January 7th, 2021, that the first patient in United Kingdom is enrolled in the company’s clinical phase IIb study in prostate cancer, a study named RhoVac-002 (“BRaVac”).

The first patient in United Kingdom is enrolled in the clinical study, called BRaVac. This clinical trial phase IIb-study is a randomized, placebo controlled and double-blind study, with the primary objective of evaluating if treatment with the drug candidate RV001 can prevent or limit the development of advanced prostate cancer after curative intent treatment. The clinical phase IIb study is an international, multicenter study, which will recruit over 175 patients in six European countries (Denmark, Finland, Sweden, Belgium, Germany and United Kingdom) and the US.

CEO Anders Månsson comments: “We are very happy about the fact that, in spite of the pandemic, we have now been able to get all countries operational in the study”.

This disclosure contains information that RhoVac is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 07-01-202115:00 CET.

CONTACT:

For further information, please contact:

Anders Månsson – CEO, RhoVac AB

Phone number: +46 73-751 72 78

E-mail: [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/rhovac/r/first-patient-in-treatment-in-rhovac-s-clinical-phase-iib-study-in-united-kingdom,c3264996

The following files are available for download:


https://mb.cision.com/Main/13747/3264996/1356856.pdf

Release

Cision View original content:http://www.prnewswire.com/news-releases/first-patient-in-treatment-in-rhovacs-clinical-phase-iib-study-in-united-kingdom-301202827.html

SOURCE RhoVac

JAGGAER and Tealbook Team up to Give Procurement Professionals Fast Access to Reliable Supplier Data

Partnership provides JAGGAER customers with powerful supplier discovery, diversity insights and data enrichment and relieves the administrative burden on suppliers.

RESEARCH TRIANGLE PARK, N.C. and MOUNTAIN VIEW, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) — JAGGAER, the leading independent spend management company, and Tealbook Inc., the “Trusted Source of Supplier Data”, today announced a new partnership to provide enriched supplier data for JAGGAER customers through access to Tealbook’s Supplier Intelligence Platform. The collaboration enables JAGGAER’s customers to find new suppliers and access accurate and comprehensive supplier information, including diversity status, compliance, certifications and more, providing JAGGAER with a competitive advantage over other portal-based supplier information, community insights and networks that come with traditional S2Ps.

Access to accurate supplier data is a huge challenge for most enterprises, hindering decision-making, innovation and resilience. Through this unique partnership, JAGGAER customers will have access to autonomously enriched supplier data tagged with diversity status, compliance and certifications linked to suppliers’ profiles within Tealbook’s Supplier Intelligence Platform. This collaboration will also enable JAGGAER customers to automate supplier profiles, removing the dependency on suppliers to update their information. Suppliers will have their profiles self-maintained in Tealbook as a complement to the JAGGAER portal.

“Access to Tealbook data, which is updated continuously and autonomously through machine learning technology, will allow JAGGAER customers across multiple vertical industries to make better decisions about suppliers faster and more easily than ever,” commented Jim Bureau, CEO, JAGGAER.

“Many of our customers are currently exploring options to diversify their mix of suppliers for a number of reasons, including the need to reduce risk, especially in response to the pandemic, and the pursuit of environmental, social, and corporate governance (ESG) objectives. Partnership with Tealbook will give customers the confidence to respond quickly to changes and opportunities by moving reliable supplier data to upstream decision-making processes. More broadly, these capabilities are yet another step forward in our march toward fully autonomous procurement, relieving both buying organizations and suppliers of the onerous burden of manual data updates,” Bureau added.

Longer term, JAGGAER and Tealbook will set out a roadmap for full integration of their respective software platforms.

Tealbook’s supplier data foundation offers an innovative and easy-to-implement approach to autonomously gathering and validating supplier information from over 400 million websites and 600 data sources. The platform helps organizations avoid supply disruptions in times of crisis, support strategic objectives like increasing spend with diverse suppliers and improve the quality and savings from strategic sourcing, especially in new categories where there is less knowledge of the market.

“Even with millions of dollars of investments in cloud S2P solutions, 93%* of supply chain and procurement executives are experiencing negative impacts to their business on a regular basis due to misinformation and poor supplier data,” commented Stephany Lapierre, CEO of Tealbook. “This includes financial loss, delayed timelines and projects, unhappy internal and external customers, termination of supplier relationships and more. The solution is Tealbook, a trusted data foundation that can be leveraged by eProcurement solutions to ensure these investments are successful.”

“We are thrilled to partner with JAGGAER to enhance JAGGAER ONE’s Spend Management Platform with the power of AI generated supplier data and our advanced supplier network,” Lapierre added. “This collaboration will allow JAGGAER customers to enhance supplier data and gain access to their entire supplier base, reducing the need for data enrichment services and dependency on suppliers to enrich and maintain portals. This partnership will enable JAGGAER customers to better utilize the spend management platform to create real-time access to their entire supplier base while expanding their vendor data to quickly identify suppliers that meet their requirements, gaining intelligence, speed and agility.”

*Source: Wakefield Research

About JAGGAER: Procurement Simplified

JAGGAER is the world’s largest independent spend management company, connecting customers to a network of 4 million suppliers in 70 countries, served by offices located in the Americas, APAC, Asia and EMEA. JAGGAER offers end-to-end SaaS-based procurement solutions, including advanced Spend Analytics, Category Management, Supplier Management, Sourcing, Contracts, eProcurement, Invoicing, Supply Chain Management and Inventory Management. These all reside on a single platform, JAGGAER ONE. JAGGAER has pioneered spend solutions for more than two decades and continues to lead the innovation curve by listening to customers and stakeholders in all industry sectors, public services and academia. JAGGAER holds 37 patents – more than any other spend management company.

JAGGAER Media Contact

Abigail Holmes
Corporate Ink for JAGGAER
[email protected]
+1 617.969.9192

About Tealbook

Tealbook is a Big Data company that provides a platform to fix enterprise supplier data forever. Tealbook does this through proprietary Autonomous Data Enrichment technology which proactively captures and maintains changing supplier information. In addition, Tealbook provides a data foundation that can be leveraged by other eProcurement solutions to ensure these larger investments are successful. Tealbook has been adopted by Fortune 100 companies across multiple sectors and is the winner of many prestigious awards including Spend Matters 50 Vendors to Watch, Gartner’s Cool Vendor, CIX Most Innovative Company and Most Upside Potential by C100. Tealbook’s mission is to deliver a ‘Trusted Source of Supplier Data’ to an ever-growing procurement space. For more information, visit www.tealbook.com.

Tealbook Media contact:

Carin Warner
[email protected]